Rosendo Lurı́a-Pérez

ORCID: 0000-0002-5822-6956
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Cancer Research and Treatments
  • Monoclonal and Polyclonal Antibodies Research
  • Nanoplatforms for cancer theranostics
  • Virus-based gene therapy research
  • RNA Interference and Gene Delivery
  • Multiple Myeloma Research and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Glycosylation and Glycoproteins Research
  • HER2/EGFR in Cancer Research
  • Erythrocyte Function and Pathophysiology
  • Acute Myeloid Leukemia Research
  • Iron Metabolism and Disorders
  • Mosquito-borne diseases and control
  • Immunotherapy and Immune Responses
  • Lymphoma Diagnosis and Treatment
  • Polyomavirus and related diseases
  • Signaling Pathways in Disease
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Healthcare during COVID-19 Pandemic
  • Antifungal resistance and susceptibility
  • Inflammasome and immune disorders
  • Pericarditis and Cardiac Tamponade

Instituto de Cancerología Las Américas
2014-2023

Hospital Infantil de México Federico Gómez
2010-2023

University of California, Los Angeles
2011-2019

Cranbrook Academy of Art
2015

APLA Health
2010-2011

Secretaria de Salud
2007

Center for Research and Advanced Studies of the National Polytechnic Institute
2005-2007

Mexican Social Security Institute
2002-2006

Centro Médico Nacional La Raza
2003

Centro de Investigación en Materiales Avanzados
2003

Haploidentical transplantation performed with post-transplantation cyclophosphamide (PTCy)–based graft-versus-host disease (GVHD) prophylaxis has been associated favorable outcomes for patients acute myeloid leukemia and lymphomas. However, it remains unclear if such approach is effective lymphoblastic (ALL). We analyzed of 109 consecutively treated ALL 18 years age older at 5 institutions. The median was 32 the follow-up survivors 13 months. Thirty-two were in first complete remission...

10.1016/j.bbmt.2016.11.008 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2016-11-14

We previously developed an antibody-avidin fusion protein (ch128.1Av) targeting the human transferrin receptor 1 (TfR1, also known as CD71), which demonstrates direct in vitro cytotoxicity against malignant hematopoietic cells. This is attributed to its ability decrease level of TfR1 leading lethal iron deprivation. now report that ch128.1Av shows bind Fcγ receptors and complement component C1q, suggesting it capable eliciting Fc-mediated effector functions such antibody-dependent...

10.1097/cji.0b013e318222ffc8 article EN Journal of Immunotherapy 2011-06-08

Arnica montana cell suspension culture could be a sustainable source of vegetal material producer secondary metabolites (SMs) possessing biological effects. Different plant growth regulator concentrations (0-5 mg/L) were tested in foliar explants to induce callus that was used establish culture. Growth kinetics carried out for 30 days. A methanolic extract obtained from biomass harvested at days fractionated, and three fractions bioactivities. We induced with 1 mg/L picloram 0.5 kinetin...

10.3390/plants10112300 article EN cc-by Plants 2021-10-26

A number of antibodies have been developed that induce lethal iron deprivation (LID) by targeting the transferrin receptor 1 (TfR1/CD71) and either neutralizing (Tf) binding, blocking internalization and/or inducing its degradation. We recombinant human TfR1 (ch128.1 ch128.1Av), which degradation are cytotoxic to certain malignant B-cells. now show bound these can lead sequestration degradation, as well reduced Tf uptake, induction a transcriptional response consistent with deprivation, is...

10.3109/10428194.2011.596964 article EN Leukemia & lymphoma/Leukemia and lymphoma 2011-08-28

The use of haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide (Haplo-PTCy) in children is increasing; however, it still not clear which preparative regimen best this setting. We present the long-term results 42 patients age <18 years high-risk leukemia who underwent procedure using a reduced-intensity conditioning (RIC) and peripheral blood as source. Twenty-six had acute lymphoblastic leukemia, 13 myelogenous 2 juvenile myelomonocytic 1...

10.1016/j.jtct.2021.02.010 article EN cc-by-nc-nd Transplantation and Cellular Therapy 2021-02-16

Despite all successful efforts to develop a COVID-19 vaccine, the need evaluate alternative antigens produce next-generation vaccines is imperative target emerging variants. Thus, second generation of employ more than one antigen from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induce an effective and lasting immune response. Here, we analyzed combination two SARS-CoV-2 viral that could elicit durable response in both T- B-cells. The nucleocapsid (N) protein, Spike protein...

10.3390/vaccines11040864 article EN cc-by Vaccines 2023-04-18

The survival of patients with Non-Hodgkin´s Lymphoma has substantially improved current treatments. Nevertheless, the appearance drug-resistant cancer cells leads to patient relapse. It is therefore necessary find new antitumor therapies that can completely eradicate transformed cells. Chemotherapy-resistant are characterized by overexpression members anti-apoptotic Bcl-2 protein family, such as Bcl-XL, and Mcl-1. We have recently shown peptides derived from BH3 domain pro-apoptotic Bax...

10.3389/fimmu.2019.02562 article EN cc-by Frontiers in Immunology 2019-11-14

Iron is essential for cell growth and imported into cells in part through the action of transferrin (Tf), a protein that binds its receptor (TfR1 or CD71) on surface cell, then releases iron endosomes. TfR1 single pass type-II transmembrane expressed at basal levels most tissues. High expression typically associated with rapidly proliferating cells, including various types cancer. targeted by experimental therapeutics several reasons: accessibility, constitutive endocytosis role...

10.1016/j.bmhime.2017.11.035 article ES Boletín Médico Del Hospital Infantil de México (English Edition) 2016-11-01

DNA priming-protein boosting is a strategy used to establish strong immunity specific pathogen by the use of two different antigens through sequential delivery systems. In this work, recombinant plasmids were used, one encoding for dengue virus E protein, which know induce neutralizing antibodies (pcDNA 3.1/E), and other Dengue nonstructural protein 1 3.1/NS1), as source B- T-cell epitopes possibly involved in protective immunity. We showed that immunization BALB/c mice with three priming...

10.1089/vim.2005.18.709 article EN Viral Immunology 2005-12-01

Salmonella enterica es una especie de bacterias anaeróbicas facultativas que han sido empleadas con gran éxito como vector bacteriano vivo atenuado fines vacunales. Recientemente se ha documentado S. tiene propiedades importantes para ser considerada agente terapéutico contra el cáncer. Estudios preclínicos y clínicos demostrado coloniza tumores sólidos, semisólidos metástasis, además contribuye a disminuir la resistencia los tratamientos. En esta revisión aborda capacidad atenuada eliminar...

10.1016/j.bmhimx.2015.02.005 article ES Boletín Médico del Hospital Infantil de México 2015-01-01

Tumor cell resistance to chemotherapy agents is one of the main problems in eradication different neoplasias. One mechanisms this process overexpression anti-apoptotic proteins such as Bcl-2 and Bcl-XL; blocking activity these may contribute sensitization tumor cells allow adequate effects chemotherapeutic drugs. This study adressed transfection prostate cancer (PC3) with a plasmid encoding recombinant protein an antagonist peptide from BH3 region Bax fused GFP reporter (BaxGFP). induced...

10.1016/j.bmhimx.2016.10.002 article ES Boletín Médico del Hospital Infantil de México 2016-11-01

Summary CD154 is a type II glycoprotein member of the tumour necrosis factor (TNF) ligand family, which expressed mainly on surface activated T lymphocytes. The interaction with its receptor CD40, plays central role in control several functions immune system. Structural models based homology TNF and lymphotoxin indicate that binding to CD40 involves three regions surrounding amino acids K143, R203 Q220, strands W140–S149 S198–A210 are critical for such interactions. Also, it has been...

10.1046/j.1365-2567.2003.01717.x article EN Immunology 2003-09-18
Coming Soon ...